GlaxoSmithKline Biologicals Sa v. Pfizer Inc

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Gregory B. Williams · 598 cases in index

Docket number

1:24-cv-00512

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

830 Patent
Infringement of a patented invention.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

04/25/2024

11,768 Patent cases in this court are indexed here.

Parties

• plaintiff · GlaxoSmithKline Biologicals Sa · 6 cases
• defendant · Pfizer, Inc Pharmaceuticals & Biotechnology · 12528 cases

Part of a Larger Litigation Pattern

This is one of 12,529 Patent cases in our index naming Pfizer, Inc — a possible mass-tort or coordinated-litigation cluster.

• Bayer CropScience LLC v. Pfizer, Inc
  District Court, D. DelawareFiled 01/06/2026
• GlaxoSmithKline Biologicals Sa v. Pfizer Inc
  District Court, D. DelawareFiled 08/02/2023
• Alnylam Pharmaceuticals, Inc v. Pfizer Inc
  District Court, D. DelawareFiled 05/26/2023
• Arbutus Pharma Corp v. Pfizer Inc
  District Court, D. New JerseyFiled 04/04/2023
• Arbutus Pharma Corp v. Pfizer Inc
  District Court, D. New JerseyFiled 04/04/2023
• ModernaTX, Inc v. Pfizer Inc
  District Court, D. MassachusettsFiled 08/26/2022

About Patent Lawsuits

Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

Frequently Asked Questions

What is GlaxoSmithKline Biologicals Sa v. Pfizer Inc?

GlaxoSmithKline Biologicals Sa v. Pfizer Inc is a federal patent lawsuit filed on 04/25/2024 in the District Court, D. Delaware. The case is currently open in the federal court system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What type of case is this?

It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:24-cv-00512.

When was the case filed?

GlaxoSmithKline Biologicals Sa v. Pfizer Inc was filed on 04/25/2024. The case is currently open.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.